SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity

导出原文传递

翻译打印收藏纠错

作者： Ueno, Hikaru ^[1] ; Ito, Ryo ^[2] ; Abe, Shin-ichi ; Ookawara, Mitsugi ; Miyashita, Hirohisa ; Ogino, Hitomi ; Miyamoto, Yasufumi ; Yoshihara, Tomoki ; Kobayashi, Akihiro ; Tsujihata, Yoshiyuki ; Takeuchi, Koji ; Watanabe, Masanori ; Yamada, Yukio ; Maekawa, Tsuyoshi ; Nishigaki, Nobuhiro ; Moritoh, Yusuke

作者单位： SCOHIA PHARMA Inc, Fujisawa, Kanagawa, Japan ^[1] Takeda Pharmaceut Co Ltd, Fujisawa, Kanagawa, Japan ^[2]

发布时间 2020-05-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

The Journal of pharmacology and experimental therapeutics.

2019年370卷2期

172-181页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity

The Journal of pharmacology and experimental therapeutics.

相似文献

The Journal of pharmacology and experimental therapeutics.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity

The Journal of pharmacology and experimental therapeutics.

相似文献

The Journal of pharmacology and experimental therapeutics.

相关期刊

检索历史清除